Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Other Non-Current Liabilities (2016 - 2025)

Mimedx's Other Non-Current Liabilities history spans 15 years, with the latest figure at $5.4 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 27.24% year-over-year to $5.4 million; the TTM value through Dec 2025 reached $5.4 million, down 27.24%, while the annual FY2025 figure was $5.4 million, 27.24% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $5.4 million at Mimedx, down from $5.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $7.5 million in Q1 2025 and bottomed at $2.2 million in Q4 2023.
  • The 5-year median for Other Non-Current Liabilities is $4.4 million (2022), against an average of $4.6 million.
  • The largest annual shift saw Other Non-Current Liabilities crashed 53.43% in 2023 before it soared 232.12% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $4.9 million in 2021, then decreased by 1.97% to $4.8 million in 2022, then plummeted by 53.43% to $2.2 million in 2023, then skyrocketed by 232.12% to $7.4 million in 2024, then dropped by 27.24% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Other Non-Current Liabilities are $5.4 million (Q4 2025), $5.5 million (Q3 2025), and $7.0 million (Q2 2025).